02-19-2007: 3M announced it has acquired Acolyte Biomedica Ltd. Acolyte Biomedica brings to 3M's infection prevention platform a pipeline of rapid culture-based screening tests for microbes, such as MRSA and vancomycin-resistant enterococcus (VRE), that simplify the diagnostic process by automating traditional culture methodology resulting in reliable confirmed 'negatives' in hours rather than days.
According to the compnay, the addition of Acolyte Biomedica allows 3M to expand more quickly into the emerging market of infection prevention diagnostics, especially in Europe where Acolyte Biomedica has commercialized product for MRSA.
3M Completes Acquisition of Ligacon AG, Filtration Supplier in Switzerland
3M announced it has completed its acquisition of Ligacon AG, a Switzerland-based manufacturer and supplier of filtration systems and filter elements for the pharmaceutical, biotech and general industrial markets. Terms of the transaction were not disclosed. As part of 3M CUNO Filtration, L ... more
3M Expands its Medical Diagnostics Platform with Acquisition of Acolyte Biomedica Ltd.
3M announced it has acquired Acolyte Biomedica Ltd. Acolyte Biomedica brings to 3M's infection prevention platform a pipeline of rapid culture-based screening tests for microbes, such as MRSA and vancomycin-resistant enterococcus (VRE), that simplify the diagnostic process by automating tra ... more
Dyneon to acquire Empore Solid Phase Extraction family of products
Dyneon LLC recently announced that it will acquire 3M's Bioanalytical Technologies business including the Empore(TM) Solid Phase Extraction family of products, effective January 1, 2007. The Bioanalytical Technologies business and Empore products will be integrated into Dyneon and will augm ... more
3M Expands its Medical Diagnostics Platform with Acquisition of Acolyte Biomedica Ltd.
3M announced it has acquired Acolyte Biomedica Ltd. Acolyte Biomedica brings to 3M's infection prevention platform a pipeline of rapid culture-based screening tests for microbes, such as MRSA and vancomycin-resistant enterococcus (VRE), that simplify the diagnostic process by automating tra ... more
Acolyte and Ploughshare Innovations Agree Exclusive Licence For Adenylate Kinase
Acolyte Biomedica Ltd and Ploughshare Innovations Ltd have negotiated and agreed an exclusive global licence for the application of Adenylate Kinase (AK) in the fields of hygiene monitoring and clean-in-place monitoring of facilities, equipment and instruments used in clinical and veterinar ... more
About analytica-world.com
analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by CHEMIE.DE, one of analytica's official sales partners.
Advertising at analytica-world.com
Our advertising formats support you in getting your message across to a clearly defined target audience.
The global network of analytica trade fairs:
